BTG Acquires Roxwood Medical

 

October 5, 2017—BTG plc announced it has acquired Roxwood Medical, a provider of advanced cardiovascular specialty catheters used in treating patients with severe coronary and peripheral artery disease. BTG stated that Roxwood's products complement its existing business and will be offered through BTG's existing Ekos hospital sales force.

According to BTG, Roxwood's anchoring catheters (CenterCross, CenterCross Ultra, MultiCross) and microcatheters (MicroCross) offer options for physicians in crossing complex lesions and arterial blockages. Roxwood's catheters incorporate a self-expanding scaffold that stabilizes the delivery of a guidewire. The devices provide positioning accuracy and support to facilitate the crossing of blockages, mitigating guidewire buckling, and enabling treatments such as angioplasty, stenting, or atherectomy.

BTG advised that it will pay up to $80 million in cash to acquire Roxwood, which includes $65 million paid on closing and up to an additional $15 million upon achievement of certain future commercial milestones.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.